Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.14 USD | -5.86% | -6.29% | +29.26% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.26% | 2.15B | |
+0.82% | 43.84B | |
+5.32% | 41.68B | |
+45.55% | 41.25B | |
-10.92% | 27.04B | |
+6.14% | 25.53B | |
-25.47% | 18.18B | |
-3.98% | 12.29B | |
+25.04% | 12.29B | |
+7.08% | 11.15B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- Kymera Therapeutics Starts Dosing Patients With Solid Tumors, Lymphomas in 2 Phase 1 Trials